We often think of ourselves as either a day person or a night person-one who rises with the sun, raring to go, or one who prefers to stay up through the night to get things done. Regardless, we each have our regular waking and sleeping cycles. It's been know for some time that variations in sleep and wakefulness are part of our circadian rhythm, or molecular clock. A portion of the brain called the hypothalamic suprachiasmatic nucleus (SCN) regulates this biorhythm. When this area of the hypothalamus is destroyed in animal models, the circadian rhythm is disrupted. Two transcription factors (proteins that regulate gene expression) called Bmal1 and Clock regulate aspects of circadian rhythm, possibly by regulating neurons in the SCN.
Other aspects of human physiology are also regulated in a circadian manner. Besides altering sleep and wakefulness patterns, ablation of the SCN alters the ability to regulate sugar levels. Sugar (glucose) levels must be maintained within fairly narrow limits for survival. This regulation is controlled in part by a balance between blood sugar level and insulin production (insulin lowers the blood sugar level). In people and in mouse models, both glucose level and insulin level are subject to circadian rhythms. It isn't clear, however, if this is a behavioral effect, whereby the disruption of the SCN might alter our feeling of being well fed-that is, being sated-as eating has a profound effect on blood sugar levels.
Garret FitzGerald and colleagues tested the effect of the molecular clock genes in glucose regulation (homeostasis) by examining mice in which Clock and Bmal1 were impaired. In normal mice they observed a peak in glucose levels early in the day. This diurnal regulation was lost in the mutant mice.
Furthermore, whereas the normal mice could fairly easily return their glucose levels to normal when they were artificially treated with insulin, this ability was severely impaired in the mutant mice. What'Page: 1 2 Related biology news :1
Contact: Paul Ocampo
Public Library of Science
. TXNIP -- regulator of glucose homeostasis and potential diabetes drug target and more2
. Study identifies glucose sensor that plays dual role in glucose metabolism and fat synthesis3
. U of M researchers invent flashy new process to turn soy oil, glucose into hydrogen4
. Chemical compounds restore normal glucose levels and insulin action in obese mice5
. Unexpected function for a key regulator of blood glucose levels6
. Low blood glucose levels may complicate gastric bypass surgery, study shows7
. Key regulator of blood glucose levels discovered8
. Scientists at Galileo Pharmaceuticals confirm inflammatory response linked to glucose levels9
. Joslin study shows weight control protects against low birth weight related glucose intolerance10
. Hydroxycitric acid slows glucose uptake, cuts insulin peaks/valleys a la South Beach Diet11
. Natural glucose byproduct may prevent brain damage and cognitive impairment after diabetic coma